HIMS241206P20500
- 0.03
- 0.000.00%
Hims & Hers Health Newsroom
Hims & Hers Named to Inc.'s 2024 Best in Business List in Health Products Category
'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape
Hims & Hers Health Options Spot-On: On December 2nd, 106.37K Contracts Were Traded, With 583.96K Open Interest
On December 2nd ET, $Hims & Hers Health(HIMS.US)$ had active options trading, with a total trading volume of 106.37K options for the day, of which put options accounted for 45.87% of the total
Unusual Options Activity: AES, HIMS and Others Attract Market Bets, AES V/OI Ratio Reaches 120.0
EST Dec 2nd Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
CCORF Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Raises Target Price to $38
Canaccord Genuity Maintains Buy on Hims & Hers Health, Raises Price Target to $38
Hims & Hers Health Analyst Ratings
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
10 Health Care Stocks With Whale Alerts In Today's Session
Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Friday; Archer Aviation, MicroStrategy to Advance
Hims & Hers Health Options Spot-On: On November 27th, 113.26K Contracts Were Traded, With 587.36K Open Interest
On November 27th ET, $Hims & Hers Health(HIMS.US)$ had active options trading, with a total trading volume of 113.26K options for the day, of which put options accounted for 35.97% of the total
Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity
Unusual Options Activity: AAL, COIN and Others Attract Market Bets, AAL V/OI Ratio Reaches 75.0
EST Nov 27th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
US stocks abnormal movement | Hims & Hers Health (HIMS.US) rose more than 5%, hitting a new all-time high.
On Wednesday, Hims & Hers Health (HIMS.US) rose more than 5%, hitting a new all-time high at $32.23.
Hims & Hers Health Insider Sold Shares Worth $3,021,496, According to a Recent SEC Filing
Hims & Hers Health(HIMS.US) Officer Sells US$3.02 Million in Common Stock
$Hims & Hers Health(HIMS.US)$ Officer Okupe Oluyemi sold 101.99K shares of common stock on Nov 25, 2024 at an average price of $29.6245 for a total value of $3.02 million.Source: Announcement What
White House Announced: Biden-Harris Administration Takes Latest Step to Lower Prescription Drug Costs by Proposing Expanded Coverage of Anti-Obesity Medications for Americans With Medicare and Medicaid
Market Participants Recognise Hims & Hers Health, Inc.'s (NYSE:HIMS) Revenues Pushing Shares 44% Higher
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
After Trump's nomination of the FDA commissioner, the supplier of "affordable weight loss drugs" Hims & Hers surged over 20%, reaching an all-time high.
"Hunterbrook Media, the institution that benchmarks against short sellers like Citron, believes that Trump's nomination of Marty Makary as the head of the usa Food and Drug Administration (FDA) could be beneficial for Hims & hers due to this appointment."